Sun Pharma Advanced Research Company Limited, a active public limited company, was established on 01 March 2006 in Manjusar, Gujarat, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: L73100GJ2006PLC047837. Registered under ROC Roc Ahmedabad. it is listed on BSE: 532872 and NSE: SPARC. It has an authorized capital of ₹42.50 Cr and a paid-up capital of ₹32.45 Cr.
It upholds a compliant status. In 2023, it reported revenue of ₹249.66 Cr and a net worth of ₹512.78 Cr. Employing 381 professional, Its leadership includes Dilip Shantilal Shanghvi (Director), Robert Jay Spiegel (Director), Rekha Gopal Warriar (Additional Director). Past directors included Andrea Thaddaus Vasella, Sailesh Trambaklal Desai, Sudhir Vrundavandas Valia. It holds ₹425.00 Cr open charges and no settled loans. Its latest AGM occurred on 12 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway,, Manjusar, Gujarat, 391775.
L73100GJ2006PLC047837
047837
01 March 2006
₹42.50 Cr
₹32.45 Cr
Roc Ahmedabad
Listed (BSE: 532872, NSE: SPARC)
Active
Explore comprehensive insights into Sun Pharma Advanced Research Company Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilip Shantilal Shanghvi | Director | 01 Mar 2006 | Current |
| Robert Jay Spiegel | Director | 01 Jun 2020 | Current |
| Rekha Gopal Warriar | Additional Director | 19 May 2025 | Current |
| Rajamannar Thennati | Director | 04 Jun 2007 | Current |
| Venkateswarlu Jasti | Additional Director | 19 May 2025 | Current |
| Vidhi Dilip Shanghvi | Director | 15 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2017 | Past |
| Pramod Abcsdd | Director | 04 Jun 2007 | Past |
| Pramod Abcsdd | Director | 31 Jul 2014 | Past |
| Pramod Abcsdd | Managing Director | 25 May 2021 | Past |
| Pramod Abcsdd | Director | 05 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sun Pharma Advanced Research Company Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 73.26% increase. The company also saw a slight decrease in profitability, with a 9.43% decrease in profit. The company's net worth Soared by an impressive increase of 1542.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sun Pharma Advanced Research Company had a promoter holding of 65.67% and a public holding of 34.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,250,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2022 | Others | ₹25.00 Cr | Open |
| 18 Feb 2021 | Others | ₹400.00 Cr | Open |
Explore comprehensive loan charge details -
Sun Pharma Advanced Research Company has a workforce of 381 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Advanced Research Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Advanced Research Company's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sun Pharma Advanced Research Company Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records. was documented.
A charge with Others of Rs. 400.00 Cr registered on 18 Feb 2021 with Charge ID 100424977 was modified on 08 Jul 2025. was recorded as a recent event.
The activity Rekha Gopal Warriar was appointed as a Additional Director was appointed as a Additional Director on 19 May 2025 & has been associated with this company since 6 months 15 days . was completed.
The activity Venkateswarlu Jasti was appointed as a Additional Director was appointed as a Additional Director on 19 May 2025 & has been associated with this company since 6 months 15 days . was completed.
Sun Pharma Advanced Research Company Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on Vidhi Dilip Shanghvi was appointed as a Director was appointed as a Director on 15 Jul 2024 & has been associated with this company since 1 year 4 months . was documented.
SCD-153 is the first-in-class topical formulation for the treatment of Alopecia Areata Sun Pharma Advanced Research Company has entered into an agreement with Johns Hopkins University (JHU) and The In.
The CIN of Sun Pharma Advanced Research Company Limited is L73100GJ2006PLC047837.
Sun Pharma Advanced Research Company Limited is headquartered at Plot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli – Vadodara Highway,, Manjusar, Gujarat, 391775.
Sun Pharma Advanced Research Company Limited was incorporated on 01 March 2006.
The current directors of Sun Pharma Advanced Research Company Limited are
The primary industry of Sun Pharma Advanced Research Company Limited is Professional, Scientific And Technical.
Sun Pharma Advanced Research Company Limited is listed. It is listed on BSE: 532872 and NSE: SPARC.
The authorized capital of Sun Pharma Advanced Research Company Limited is ₹42.50 Cr, and the paid-up capital is ₹32.45 Cr.
The compliance status of Sun Pharma Advanced Research Company Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX